Sotagliflozin use linked to reduced risk of heart attack, heart failure and stroke in diabetics: Study Medha Baranwal15 July 2021 9:00 AM ISTSotagliflozin is not FDA approved and if it is brought to the market, it would signify a major advance in the care of patients with diabetes,...
Tirzepatide provides significant blood sugar and weight reduction in diabetics: SURPASS Trial Hina Zahid14 July 2021 11:45 AM ISTTirzepatide is delivering unprecedented results that could help millions of people with type 2 diabetes and their health care providers reach A1C and...
Liraglutide and insulin most effective in maintaining optimal blood sugar levels in diabetics: Study Medha Baranwal13 July 2021 11:00 AM ISTResults of GRADE demonstrated that liraglutide and insulin were the most effective of the four medications in keeping A1C levels less than...
Efpeglenatide lowers CV and kidney disease risk in high-risk diabetes patients: Study Medha Baranwal10 July 2021 10:15 AM ISTThe cardiovascular and renal benefits occurred independently of the baseline use of SGLT2 inhibitors, the baseline use of metformin, and the baseline...
Hospitalization for diabetes in children doubled during COVID-19 pandemic: Study Hina Zahid7 July 2021 9:00 AM ISTThe findings reinforces the importance of maintaining a healthy lifestyle for children even under such difficult circumstances of COVID-19...
Finerenone improves kidney outcomes in patients of CKD with diabetes: Study Medha Baranwal2 July 2021 9:00 AM ISTDelhi: Finerenone exerts renoprotective benefits in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) irrespective of absence or...
Dapagliflozin reduces risk of new type 2 diabetes in CKD patients: Study Medha Baranwal30 Jun 2021 9:00 AM ISTDelhi: Treatment with dapagliflozin in chronic kidney disease (CKD) patients significantly reduced the risk of new-onset type 2 diabetes (T2D), show...
Regular efpeglenatide use significantly reduces cardiorenal events in diabetics: AMPLITUDE O Trial Medha Baranwal29 Jun 2021 10:15 AM ISTUSA: Weekly injection of efpeglenatide has the potential to improve outcomes for high-risk diabetes patients with heart or kidney disease, shows...
Tirzepatide bests semaglutide for blood sugar and weight control in diabetics: SURPASS-2 Medha Baranwal28 Jun 2021 10:21 AM ISTUSA: Tirzepatide showed superior management of blood sugar levels and weight loss compared to semaglutide in type 2 diabetes patients receiving...
